Smithbridge Asset Management reduced its Amgen stock holding by 10.1%, while Amgen reported a 19.8% revenue increase in Q4.

Smithbridge Asset Management Inc. reduced its stock holdings in Amgen Inc. by 10.1% in the fourth quarter, while other institutional investors, including Roundview Capital LLC, Merit Financial Group LLC, and Fuller & Thaler Asset Management Inc., adjusted their stakes in the biotech company. Amgen reported a 19.8% year-over-year revenue increase for the quarter, earning $4.71 EPS, beating analyst estimates by $0.05. Analysts expect Amgen to post 19.49 EPS for the current fiscal year.

March 28, 2024
11 Articles

Further Reading